Alphatec Holdings, Inc. (ATEC) Stock Analysis

Verdict: WATCH (do not buy)

Hardware adoption (+17% case growth) is obscured by biologics softness and $620M debt, creating a high-volatility turn-around setup.

Investment score: 42/100

Analysis as of

Is Alphatec Holdings, Inc. stock worth reviewing? The TradeMates thesis

Alphatec trades near its 52-week low ($7.34) after a 32.3% 5-day post-earnings decline, caused by an FY2026 revenue guidance cut to ~$862M despite solid 17% surgical hardware case growth.

7-factor investment score

Alphatec Holdings, Inc. opportunities and risks

What speaks for ATEC

What speaks against ATEC

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
ATECn/a1.3x50.9x66.7%-10.3%0.4%
CNMD19.5x1.0x10.3x57.2%5.4%9.4%
TNDMn/a1.2xn/a56.0%-6.1%-2.1%
KMTSn/a16.8xn/a53.9%-140.4%-6.8%
ENOVn/a0.5xn/a57.4%-48.0%5.2%
AORTn/a2.5x29.3x62.8%-0.7%-0.9%
Peer mediann/a1.2xn/a57.2%-6.1%-0.9%

Frequently asked questions about Alphatec Holdings, Inc. (ATEC)

Is ATEC stock a good investment?

The TradeMates model rates Alphatec Holdings, Inc. as WATCH (do not buy) with an investment score of 42/100. Alphatec trades near its 52-week low ($7.34) after a 32.3% 5-day post-earnings decline, caused by an FY2026 revenue guidance cut to ~$862M despite solid 17% surgical hardware case growth. This is algorithmic model output, not personal investment advice.

Is ATEC stock a buy?

The TradeMates model verdict for ATEC is WATCH (do not buy) with an investment score of 42/100. Treat this as a model signal to review, not a personal buy recommendation.